When is streptomycin indicated for abdominal tuberculosis and what is the recommended dosing schedule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Streptomycin in Abdominal Tuberculosis

Streptomycin can be used as part of the initial intensive phase for abdominal tuberculosis when drug resistance is suspected or proven, but it is not routinely indicated for drug-sensitive disease. The standard treatment for abdominal TB follows the same regimen as pulmonary TB: a 6-month course with isoniazid, rifampin, pyrazinamide, and ethambutol for 2 months, followed by isoniazid and rifampin for 4 months 1, 2.

When Streptomycin Is Indicated

Streptomycin should be added to the standard regimen in the following situations:

  • Suspected or proven drug resistance, particularly when isoniazid resistance is likely (patients from high-incidence countries where primary resistance exceeds 4%) 1
  • As a substitute for ethambutol in the initial phase when ethambutol is contraindicated or not tolerated 1
  • Drug-resistant tuberculosis where susceptibility testing demonstrates streptomycin sensitivity 2

Important caveat: Streptomycin and ethambutol are approximately equivalent in efficacy for initial treatment, but high rates of streptomycin resistance in many populations limit its usefulness 1.

Dosing Schedule

Adults:

  • Initial intensive phase: 15 mg/kg/day (maximum 1 g/day) intramuscularly, given as a single daily dose 5-7 days/week 1, 2
  • After 2-4 months or culture conversion: Reduce to 2-3 times weekly at 12-15 mg/kg per dose 1
  • Patients >59 years: Reduce to 10 mg/kg/day (750 mg maximum) due to increased toxicity risk 1, 2
  • Maximum cumulative dose: 120 g over the entire treatment course 2

Intermittent Dosing Options:

  • Thrice weekly: 25-30 mg/kg (maximum 1.5 g) 2
  • Twice weekly: 25-30 mg/kg (maximum 1.5 g) 2

Children:

  • Daily: 20-40 mg/kg/day (maximum 1 g/day) 1, 2
  • Thrice weekly: 25-30 mg/kg (maximum 1.5 g) 2

Critical Monitoring Requirements

Baseline assessments 1:

  • Audiogram
  • Vestibular testing
  • Romberg testing
  • Serum creatinine

Monthly monitoring 1:

  • Renal function assessment
  • Questioning about auditory or vestibular symptoms
  • Repeat audiogram and vestibular testing if symptoms develop

Special Populations and Contraindications

Absolute Contraindications:

  • Pregnancy: Streptomycin causes fetal ototoxicity and hearing loss 1, 3

Use with Extreme Caution:

  • Renal insufficiency: Reduce dosing frequency to 2-3 times weekly, but maintain the mg/kg dose at 12-15 mg/kg to preserve bactericidal effect. Give after dialysis in hemodialysis patients. Monitor serum drug concentrations 1, 4
  • Elderly patients (>60 years): Mandatory dose reduction due to increased ototoxicity and nephrotoxicity risk 1, 2
  • Concurrent loop diuretics: Significantly increases ototoxicity risk 1

Hepatic Disease:

No dose adjustment necessary 1

Key Toxicities

Ototoxicity (most important):

  • Vestibular and hearing disturbances
  • Risk increases with cumulative doses >100-120 g
  • Risk increases with age and concurrent diuretics 1

Nephrotoxicity:

  • Less common than with amikacin or kanamycin
  • Requires discontinuation in ~2% of patients 1

Neurotoxicity:

  • Circumoral paresthesias common immediately after injection
  • Rarely causes postoperative respiratory muscle weakness with muscle relaxants 1

Clinical Pearls

  • Poor CNS penetration: Only slight diffusion into CSF even with meningitis, making it unsuitable for TB meningitis 1
  • Resistance patterns: Most streptomycin-resistant strains remain susceptible to amikacin and kanamycin 1
  • Administration: Intramuscular injection only; preferred site is upper outer quadrant of buttock in adults 2
  • For abdominal TB specifically: There is no evidence that abdominal TB requires different treatment than pulmonary TB; the same 6-month regimen applies 5, 3

References

1
Guideline

treatment of tuberculosis.

MMWR Recommendations and Reports, 2003

Related Questions

What are the recommended anti‑tuberculosis medication doses for a patient weighing 62.5 kg?
What is the most appropriate anti‑tuberculosis regimen, including adjunctive therapy, for a 35‑year‑old Indian man with a three‑month history of lethargy, weight loss, headache, and PCR‑confirmed Mycobacterium tuberculosis?
What is the recommended anti‑tuberculosis treatment regimen for a patient with CT findings suggestive of active pulmonary tuberculosis?
Can itraconazole be co‑administered with the standard four‑drug anti‑tuberculosis regimen (isoniazid, rifampin, pyrazinamide, ethambutol)?
What laboratory tests are recommended for a patient who has recently completed tuberculosis (TB) treatment?
A patient with bipolar disorder who stopped lamotrigine (Lamictal) 400 mg daily for 5 days—how should the medication be restarted?
Should the metformin dose be increased in a patient with polycystic ovary syndrome?
Does the lamotrigine (Lamictal) dose need to be increased in patients with polycystic ovary syndrome (PCOS) for bipolar disorder?
Should a 60-year-old woman with a blood pressure of 205/100 mm Hg and headache be sent to the emergency department?
What is the appropriate maintenance fluid regimen for an adult patient with serum creatinine 3.0 mg/dL (estimated GFR ≈ 20 mL/min)?
Which specialist should a male patient who has sex with men be referred to for a suspected anal fissure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.